Abstract:Ulcerative colitis (UC) is an inflammatory bowel disease with an increasing prevalence year over year, and the medications used to treat patients with UC clinically have severe side effects. Oyster peptides (OPs) have anti-inflammatory and antioxidant properties as functional foods that can alleviate a wide range of inflammatory conditions. However, the application of oyster peptides in ulcerative colitis is not well studied. In this work, an animal model of acute colitis was established using 3% dextran sulfate sodium (DSS), and the impact of OP therapy on colitis in mice was examined. Supplementing with OPs prevented DSS-induced colitis from worsening, reduced the expression of oxidative stress and inflammatory markers, and restored the intestinal barrier damage caused by DSS-induced colitis in mice. The 16S rDNA results showed that the OP treatment improved the gut microbiota structure of the UC mice, including increasing microbial diversity, increasing beneficial bacteria, and decreasing harmful bacteria. In the UC mice, the OP therapy decreased the relative abundance of Family_XIII_AD3011_group and Prevotella_9 and increased the relative abundance of Alistipes. In conclusion, OP treatment can inhibit the TLR4/NF-κB pathway and improve the intestinal microbiota in UC mice, which in turn alleviates DSS-induced colitis, providing a reference for the treatment of clinical UC patients.

What problem does this paper attempt to address?

This paper primarily explores the role and potential mechanisms of Oyster Peptides (OPs) in the treatment of Dextran Sulfate Sodium (DSS)-induced Ulcerative Colitis (UC). ### Research Background - Ulcerative colitis is a chronic inflammatory bowel disease with an increasing prevalence, becoming a global public health issue. - Current medications for treating ulcerative colitis, such as corticosteroids, aminosalicylates, and immunosuppressants, often come with severe side effects. - Oyster peptides, as a functional food ingredient with anti-inflammatory and antioxidant properties, can alleviate various inflammatory conditions, but their application in ulcerative colitis is less studied. ### Main Research Content - An acute colitis mouse model was constructed by administering 3% DSS to simulate ulcerative colitis. - The study investigated the effects of oyster peptides on DSS-induced colitis in mice, finding that oyster peptide supplementation could prevent the worsening of DSS-induced colitis, reduce the expression of oxidative stress and inflammatory markers, and repair intestinal barrier damage caused by DSS-induced colitis. - 16S rDNA sequencing analysis revealed that oyster peptide treatment improved the gut microbiota structure in ulcerative colitis mice, including increased microbial diversity, higher numbers of beneficial bacteria, and reduced numbers of harmful bacteria. - Specifically, oyster peptide treatment reduced the relative abundance of Family_XIII_AD3011_group and Prevotella_9, and increased the relative abundance of Alistipes. - The paper concludes that oyster peptides can alleviate DSS-induced colitis by inhibiting the TLR4/NF-κB signaling pathway and improving the gut microbiota in ulcerative colitis mice, providing a reference for the treatment of clinical ulcerative colitis patients. ### Summary This paper aims to explore the therapeutic potential of oyster peptides for ulcerative colitis. The experiments found that oyster peptides effectively alleviate DSS-induced colitis symptoms in mice, with mechanisms possibly related to regulating gut microbiota structure and inhibiting the TLR4/NF-κB signaling pathway. These findings provide a theoretical basis for developing new treatment methods for ulcerative colitis.

Oyster Peptides Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis via Modulating the Gut Microbiota and Inhibiting the TLR4/NF-κB Pathway

Oyster Polysaccharides Relieve DSS-induced Colitis Via Anti-Inflammatory and Maintaining the Physiological Hypoxia.

Oat Peptides Alleviate Dextran Sulfate Sodium Salt-Induced Colitis by Maintaining the Intestinal Barrier and Modulating the Keap1-Nrf2 Axis

Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation

Analysis of metagenome and metabolome disclosed the mechanisms of Dendrobium officinale polysaccharide on DSS-induced ulcerative colitis-affected mice

Sea Cucumber Peptides Ameliorate DSS-Induced Ulcerative Colitis: the Role of the Gut Microbiota, the Intestinal Barrier, and Macrophage Polarization

Oligosaccharides of Polygonatum Cyrtonema Hua ameliorates dextran sulfate sodium-induced colitis and regulates the gut microbiota

Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms

Dendrobium Officinale Polysaccharides Alleviated DSS-induced Ulcerative Colitis in Mice Through Remolding Gut Microbiota to Regulate Purine Metabolism

The Preventive Effect of Low-Molecular Weight Oyster Peptides on Lipopolysaccharide-Induced Acute Colitis in Mice by Modulating Intestinal Microbiota Communities

Dietary Oyster (Crassostrea gigas) Extract Ameliorates Dextran Sulfate Sodium-Induced Chronic Experimental Colitis by Improving the Composition of Gut Microbiota in Mice

Ameliorative Effects of Peptides Derived from Oyster (Crassostrea gigas) on Immunomodulatory Function and Gut Microbiota Structure in Cyclophosphamide-Treated Mice

Alginate Oligosaccharides Ameliorate DSS-Induced Colitis through Modulation of AMPK/NF-κB Pathway and Intestinal Microbiota

Sulfated polysaccharides from pacific abalone attenuated DSS-induced acute and chronic ulcerative colitis in mice via regulating intestinal micro-ecology and the NF-κB pathway

Protective Effect of Alpinia oxyphylla Fructus Polysaccharides Extracted with Different Solvents on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice

A Tetrapeptide from Maize Combined with Probiotics Exerted Strong Anti-Inflammatory Effects and Modulated Gut Microbiota in DSS-induced Colitis Mice

Protective effect of 1,3-dioleoyl-2-palmitoylglycerol against DSS-induced colitis via modulating gut microbiota and maintaining intestinal epithelial barrier integrity

Therapeutic Roles of Polysaccharides from Dendrobium Officinaleon Colitis and Its Underlying Mechanisms.

Oat β-glucan ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice.

4-Octyl itaconate alleviates dextran sulfate sodium-induced ulcerative colitis in mice via activating the KEAP1-NRF2 pathway

Polysaccharide from fermented mycelium of Inonotus obliquus attenuates the ulcerative colitis and adjusts the gut microbiota in mice